Site US0002 — Stanford, California

Site US0002 is a clinical research site located in Stanford, California, United States 94305.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Site US0002 has participated in 1 clinical trials.

Therapeutic areas: Relapsed Lymphoid Malignancy, Refractory Lymphoid Malignancy.

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US0002?

Site US0002 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US0002 conducted?

Site US0002 has 1 clinical trials on record. Their work covers Relapsed Lymphoid Malignancy, Refractory Lymphoid Malignancy.

Is Site US0002 accredited by Crixeo Health?

Site US0002 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US0002?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.